Modeling the oxidation of methionine residues by peroxides in proteins.

We report the use of molecular modeling to predict the oxidation propensity of methionine residues in proteins. Oxidation of methionine to the sulfoxide form is one of the major degradation pathways for therapeutic proteins. Oxidation can occur during production, formulation, or storage of pharmaceuticals and it often reduces or eliminates biological activity. We use a molecular model based on atomistic simulations called 2-shell water coordination number to predict the oxidation rates for several model proteins and therapeutic candidates. In addition, we implement models that are based on static and simulation average of the solvent-accessible area (SAA) for either the side chain or the sulfur atom in the methionine residue. We then compare the results from the different models against the experimentally measured relative rates of methionine oxidation. We find that both the 2-shell model and the simulation-averaged SAA models are accurate in predicting the oxidation propensity of methionine residues for the proteins tested. We also find the appropriate parameter ranges where the models are most accurate. These models have significant predictive power and can be used to enable further protein engineering or to guide formulation approaches in stabilizing the unstable methionine residues.

[1]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[2]  R. Dean,et al.  Biochemistry and pathology of radical-mediated protein oxidation. , 1997, The Biochemical journal.

[3]  E. Stadtman,et al.  Methionine residues as endogenous antioxidants in proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Bernhardt L Trout,et al.  Molecular dynamics simulations and oxidation rates of methionine residues of granulocyte colony-stimulating factor at different pH values. , 2004, Biochemistry.

[5]  W. Vogt Oxidation of methionyl residues in proteins: tools, targets, and reversal. , 1995, Free radical biology & medicine.

[6]  H. Friesen,et al.  Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities. , 1987, The Journal of biological chemistry.

[7]  Bernard R Brooks,et al.  A comprehensive picture of non-site specific oxidation of methionine residues by peroxides in protein pharmaceuticals. , 2004, Journal of pharmaceutical sciences.

[8]  Bernhardt L Trout,et al.  A structural and mechanistic study of the oxidation of methionine residues in hPTH(1-34) via experiments and simulations. , 2004, Biochemistry.

[9]  T. Nguyen,et al.  The Kinetics of Relaxin Oxidation by Hydrogen Peroxide , 1993, Pharmaceutical Research.

[10]  C. Schöneich,et al.  Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition. , 2001, Journal of pharmaceutical sciences.

[11]  R T Borchardt,et al.  Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization. , 1995, Biotechnology and bioengineering.

[12]  E. Stadtman,et al.  Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. , 1993, Annual review of biochemistry.

[13]  Krzysztof Fidelis,et al.  CASP10 results compared to those of previous CASP experiments , 2014, Proteins.

[14]  B. Brooks,et al.  Oxidation of methionine residues in aqueous solutions: free methionine and methionine in granulocyte colony-stimulating factor. , 2004, Journal of the American Chemical Society.

[15]  B. Kerwin Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. , 2008, Journal of pharmaceutical sciences.

[16]  C. Schöneich,et al.  Loss of conformational stability in calmodulin upon methionine oxidation. , 1998, Biophysical journal.

[17]  Bernhardt L Trout,et al.  Comparative oxidation studies of methionine residues reflect a structural effect on chemical kinetics in rhG-CSF. , 2006, Biochemistry.

[18]  Gang Huang,et al.  Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn , 2009, Protein science : a publication of the Protein Society.

[19]  V. Uversky,et al.  Role of individual methionines in the fibrillation of methionine-oxidized α-synuclein , 2004 .

[20]  Krzysztof Fidelis,et al.  CASP9 results compared to those of previous casp experiments , 2011, Proteins.

[21]  D. Brems,et al.  Oxidation of methionine residues in recombinant human interleukin-1 receptor antagonist: implications of conformational stability on protein oxidation kinetics. , 2007, Biochemistry.

[22]  Bernhardt L Trout,et al.  On the mechanisms of oxidation of organic sulfides by H2O2 in aqueous solutions. , 2004, Journal of the American Chemical Society.

[23]  Charles L. Cooney,et al.  Relationship between Protein Structure and Methionine Oxidation in Recombinant Human α1-Antitrypsin , 2002 .

[24]  Hui Xu,et al.  Evaluation of hydroperoxides in common pharmaceutical excipients. , 2007, Journal of pharmaceutical sciences.

[25]  Brian M. Murphy,et al.  Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.

[26]  B. Lee,et al.  The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.

[27]  W. Stites,et al.  Comparing the effect on protein stability of methionine oxidation versus mutagenesis: steps toward engineering oxidative resistance in proteins. , 2001, Protein engineering.

[28]  J L Cleland,et al.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.

[29]  E. Stadtman Role of oxidant species in aging. , 2004, Current medicinal chemistry.

[30]  W Wang,et al.  Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.

[31]  Riccardo Torosantucci,et al.  Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences , 2014, Pharmaceutical Research.